000 01382 a2200385 4500
005 20250513070809.0
264 0 _c19940131
008 199401s 0 0 eng d
022 _a0011-9059
024 7 _a10.1111/j.1365-4362.1993.tb02779.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLebwohl, M
245 0 0 _aLimited application of mometasone furoate on the face and intertriginous areas: analysis of safety and efficacy.
_h[electronic resource]
260 _bInternational journal of dermatology
_cNov 1993
300 _a830-1 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Cutaneous
650 0 4 _aAnti-Inflammatory Agents
_xadministration & dosage
650 0 4 _aDermatitis, Atopic
_xdrug therapy
650 0 4 _aFacial Dermatoses
_xdrug therapy
650 0 4 _aFollow-Up Studies
650 0 4 _aGlucocorticoids
650 0 4 _aHumans
650 0 4 _aIntertrigo
_xdrug therapy
650 0 4 _aMometasone Furoate
650 0 4 _aOintments
650 0 4 _aPregnadienediols
_xadministration & dosage
650 0 4 _aPsoriasis
_xdrug therapy
650 0 4 _aSafety
650 0 4 _aTime Factors
700 1 _aPeets, E
700 1 _aChen, V
773 0 _tInternational journal of dermatology
_gvol. 32
_gno. 11
_gp. 830-1
856 4 0 _uhttps://doi.org/10.1111/j.1365-4362.1993.tb02779.x
_zAvailable from publisher's website
999 _c8269631
_d8269631